Our dedicated team works to identify and validate pharmacodynamic, target engagement and selection biomarkers using preclinical in vitro and in vivo models, tailored to your needs. We profile the clinical indication space with our tissue biobank to pinpoint patient populations relevant to your research. By leveraging biomarkers, we provide valuable insights into the pharmacokinetic/ pharmacodynamic (PK/PD) relationship of novel drug candidates. Additionally, we analyse biomarkers from your clinical trial samples to help ensure seamless translation of preclinical findings to clinical applications.
We offer integrated biomarker services, covering the entire drug discovery value chain—from preclinical biomarker discovery and validation to robust assay development, indication space population profiling and biomarker analysis of clinical samples. Our experienced biomarker scientists, with a decade-long background in the pharma industry, bring extensive knowledge across various therapeutic areas and modalities. We have a proven track record of successfully translating your drug discovery programs into clinical applications, ensuring your research progresses smoothly and effectively.
Our hypothesis-free global and mode-of-action hypothesis-driven approaches are tailored to your research needs.
Learn More
Discover the power of in vivo biomarker analysis to bridge the gap between preclinical research and clinical success.
Learn More
Our teams offer biomarker validation to confirm clinical relevance of your biomarkers across both preclinical and patient samples.
Learn More
Contact Us
Search